44,794 Spam-Free Article(s) Found
Article Searches
For Shame! 80% of Taxpayers Gave the Federal Government a $2,851 Interest-Free Loan in 2016 https://www.fool.com/taxes/2017/04/22/for-shame-80-of-taxpayers-gave-the-federal-governm.aspx?source=iedfolrf0000001 Apr 22, 2017 - Contrary to popular belief, netting a large tax refund from the federal government isn't good news.
3 Things to Look for in Illumina's Q1 Results https://www.fool.com/investing/2017/04/22/3-things-to-look-for-in-illuminas-q1-results.aspx?source=iedfolrf0000001 Apr 22, 2017 - Illumina reports Q1 results on Tuesday, April 25. Here's what to look for.
Is Tucows the Best Small-Cap Growth Stock You've Never Heard of? https://www.fool.com/investing/2017/04/22/is-tucows-the-best-small-cap-growth-stock-youve-ne.aspx?source=iedfolrf0000001 Apr 22, 2017 - This under-the-radar company is executing its unique playbook to perfection.
Samsung's Galaxy S8 Success Will Come at a Cost https://www.fool.com/investing/2017/04/21/samsungs-galaxy-s8-success-will-come-at-a-cost.aspx?source=iedfolrf0000001 Apr 22, 2017 - And what it means for Apple.
Twitter Wants to Litter Your Timeline With Video Ads https://www.fool.com/investing/2017/04/21/twitter-wants-to-litter-your-timeline-with-video-a.aspx?source=iedfolrf0000001 Apr 21, 2017 - Twitter recently introduced a new video-ad format, but will that help it grow revenue?
Why Immunomedics, Inc. Got Hammered Today https://www.fool.com/investing/2017/04/21/why-immunomedics-inc-got-hammered-today.aspx?source=iedfolrf0000001 Apr 21, 2017 - Sometimes it's what a company doesn't do that matters.
Why Briggs & Stratton Stock Climbed 9% Today https://www.fool.com/investing/2017/04/21/why-briggs-stratton-stock-climbed-9-today.aspx?source=iedfolrf0000001 Apr 21, 2017 - Investors applaud a big improvement in Q3 earnings.
2 Reasons Procter & Gamble Co. Is a Better Dividend Stock Than Kimberly Clark Co. https://www.fool.com/investing/2017/04/21/2-reasons-procter-gamble-co-is-a-better-dividend-s.aspx?source=iedfolrf0000001 Apr 21, 2017 - Why income investors should prefer P&G over its consumer goods rival today.
Here's Why Corecept Therapeutics Incorporated Had a Rough Day https://www.fool.com/investing/2017/04/21/corecept-therapeutics-incorporated-skidded-today-c.aspx?source=iedfolrf0000001 Apr 21, 2017 - Korlym's driving growth now, but investors would like to see more drugs in development.
Top Research Reports for Today: VZ, KO, SBUX http://www.zacks.com/research-daily/110988/top-research-reports-for-today-vz-ko-sbux?cid=CS-ZC-FT-110988 Apr 21, 2017 - Top Research Reports for Today: VZ, KO, SBUX
<<<Page 4376>